Case | HBS Case Collection | April 2011 (Revised July 2012)

Cipla 2011

by Rohit Deshpande, Sandra J. Sucher and Laura Winig

Abstract

Dr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.

Keywords: pharmaceutical industry; corporate strategy; leadership; Leading Change; Leadership Style; Management Teams; Governance Compliance; Corporate Strategy; Pharmaceutical Industry;

Citation:

Deshpande, Rohit, Sandra J. Sucher, and Laura Winig. "Cipla 2011." Harvard Business School Case 511-050, April 2011. (Revised July 2012.)